- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 8 x CA: CALCIUM ION(Non-covalent)
- CA.2: 5 residues within 4Å:- Chain A: D.367, R.514, S.533, E.535, S.600
 5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.367, A:R.514, A:S.533, A:E.535, A:S.600
 - CA.3: 6 residues within 4Å:- Chain A: Q.889, D.892, Q.893, D.895, D.897
- Chain D: N.449
 5 PLIP interactions:5 interactions with chain A- Metal complexes: A:Q.889, A:D.892, A:D.895, A:D.895, A:D.897
 - CA.19: 5 residues within 4Å:- Chain B: D.367, R.514, S.533, E.535, S.600
 5 PLIP interactions:5 interactions with chain B- Metal complexes: B:D.367, B:R.514, B:S.533, B:E.535, B:S.600
 - CA.20: 6 residues within 4Å:- Chain A: N.449
- Chain B: Q.889, D.892, Q.893, D.895, D.897
 5 PLIP interactions:5 interactions with chain B- Metal complexes: B:Q.889, B:D.892, B:D.895, B:D.895, B:D.897
 - CA.33: 5 residues within 4Å:- Chain C: D.367, R.514, S.533, E.535, S.600
 5 PLIP interactions:5 interactions with chain C- Metal complexes: C:D.367, C:R.514, C:S.533, C:E.535, C:S.600
 - CA.34: 6 residues within 4Å:- Chain B: N.449
- Chain C: Q.889, D.892, Q.893, D.895, D.897
 5 PLIP interactions:5 interactions with chain C- Metal complexes: C:Q.889, C:D.892, C:D.895, C:D.895, C:D.897
 - CA.47: 5 residues within 4Å:- Chain D: D.367, R.514, S.533, E.535, S.600
 5 PLIP interactions:5 interactions with chain D- Metal complexes: D:D.367, D:R.514, D:S.533, D:E.535, D:S.600
 - CA.48: 6 residues within 4Å:- Chain C: N.449
- Chain D: Q.889, D.892, Q.893, D.895, D.897
 5 PLIP interactions:5 interactions with chain D- Metal complexes: D:Q.889, D:D.892, D:D.895, D:D.895, D:D.897
 
- 32 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)(Non-functional Binders)
- POV.4: 7 residues within 4Å:- Chain A: F.306, G.310, M.314, S.317, Y.318
- Chain B: I.323
- Ligands: POV.15
 Ligand excluded by PLIP- POV.5: 4 residues within 4Å:- Chain A: R.20, W.22, L.26, F.266
 Ligand excluded by PLIP- POV.6: 1 residues within 4Å:- Ligands: CLR.9
 Ligand excluded by PLIP- POV.7: 2 residues within 4Å:- Chain A: G.125, F.148
 Ligand excluded by PLIP- POV.8: 1 residues within 4Å:- Chain A: M.21
 Ligand excluded by PLIP- POV.12: 5 residues within 4Å:- Chain A: N.328
- Chain D: T.245, T.248, F.252
- Ligands: POV.49
 Ligand excluded by PLIP- POV.13: 9 residues within 4Å:- Chain A: T.273, W.275, E.276, V.278, Y.279
- Chain D: E.264, T.298, L.302
- Ligands: CLR.54
 Ligand excluded by PLIP- POV.14: 3 residues within 4Å:- Chain A: S.135, W.275
- Ligands: CLR.54
 Ligand excluded by PLIP- POV.15: 5 residues within 4Å:- Chain A: T.245, T.248, F.252
- Chain B: N.328
- Ligands: POV.4
 Ligand excluded by PLIP- POV.16: 9 residues within 4Å:- Chain A: E.264, T.298, L.302
- Chain B: T.273, W.275, E.276, V.278, Y.279
- Ligands: CLR.9
 Ligand excluded by PLIP- POV.17: 3 residues within 4Å:- Chain B: S.135, W.275
- Ligands: CLR.9
 Ligand excluded by PLIP- POV.21: 5 residues within 4Å:- Chain B: T.245, T.248, F.252
- Chain C: N.328
- Ligands: POV.22
 Ligand excluded by PLIP- POV.22: 7 residues within 4Å:- Chain B: F.306, G.310, M.314, S.317, Y.318
- Chain C: I.323
- Ligands: POV.21
 Ligand excluded by PLIP- POV.23: 4 residues within 4Å:- Chain B: R.20, W.22, L.26, F.266
 Ligand excluded by PLIP- POV.24: 1 residues within 4Å:- Ligands: CLR.28
 Ligand excluded by PLIP- POV.25: 2 residues within 4Å:- Chain B: G.125, F.148
 Ligand excluded by PLIP- POV.26: 1 residues within 4Å:- Chain B: M.21
 Ligand excluded by PLIP- POV.27: 8 residues within 4Å:- Chain B: E.264, T.298, L.302
- Chain C: T.273, W.275, E.276, Y.279
- Ligands: CLR.28
 Ligand excluded by PLIP- POV.31: 1 residues within 4Å:- Ligands: CLR.28
 Ligand excluded by PLIP- POV.35: 7 residues within 4Å:- Chain C: F.306, G.310, M.314, S.317, Y.318
- Chain D: I.323
- Ligands: POV.44
 Ligand excluded by PLIP- POV.36: 4 residues within 4Å:- Chain C: R.20, W.22, L.26, F.266
 Ligand excluded by PLIP- POV.37: 1 residues within 4Å:- Ligands: CLR.41
 Ligand excluded by PLIP- POV.38: 2 residues within 4Å:- Chain C: G.125, F.148
 Ligand excluded by PLIP- POV.39: 1 residues within 4Å:- Chain C: M.21
 Ligand excluded by PLIP- POV.40: 9 residues within 4Å:- Chain C: E.264, T.298, L.302
- Chain D: T.273, W.275, E.276, V.278, Y.279
- Ligands: CLR.41
 Ligand excluded by PLIP- POV.44: 5 residues within 4Å:- Chain C: T.245, T.248, F.252
- Chain D: N.328
- Ligands: POV.35
 Ligand excluded by PLIP- POV.45: 2 residues within 4Å:- Chain D: W.275
- Ligands: CLR.41
 Ligand excluded by PLIP- POV.49: 7 residues within 4Å:- Chain A: I.323
- Chain D: F.306, G.310, M.314, S.317, Y.318
- Ligands: POV.12
 Ligand excluded by PLIP- POV.50: 4 residues within 4Å:- Chain D: R.20, W.22, L.26, F.266
 Ligand excluded by PLIP- POV.51: 1 residues within 4Å:- Ligands: CLR.54
 Ligand excluded by PLIP- POV.52: 2 residues within 4Å:- Chain D: G.125, F.148
 Ligand excluded by PLIP- POV.53: 1 residues within 4Å:- Chain D: M.21
 Ligand excluded by PLIP
- 12 x CLR: CHOLESTEROL(Non-covalent)
- CLR.9: 5 residues within 4Å:- Chain A: W.263, L.302
- Ligands: POV.6, POV.16, POV.17
 2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.263, A:L.302
 - CLR.10: 2 residues within 4Å:- Chain A: W.23, M.30
 4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:W.23, A:W.23, A:M.30
- Hydrogen bonds: A:Q.19
 - CLR.11: 3 residues within 4Å:- Chain A: V.97, W.100, I.169
 5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:V.97, A:W.100, A:W.100, A:W.100, A:I.169
 - CLR.28: 5 residues within 4Å:- Chain B: W.263, L.302
- Ligands: POV.24, POV.27, POV.31
 2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:W.263, B:L.302
 - CLR.29: 2 residues within 4Å:- Chain B: W.23, M.30
 4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:W.23, B:W.23, B:M.30
- Hydrogen bonds: B:Q.19
 - CLR.30: 3 residues within 4Å:- Chain B: V.97, W.100, I.169
 5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:V.97, B:W.100, B:W.100, B:W.100, B:I.169
 - CLR.41: 5 residues within 4Å:- Chain C: W.263, L.302
- Ligands: POV.37, POV.40, POV.45
 2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:W.263, C:L.302
 - CLR.42: 2 residues within 4Å:- Chain C: W.23, M.30
 4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:W.23, C:W.23, C:M.30
- Hydrogen bonds: C:Q.19
 - CLR.43: 3 residues within 4Å:- Chain C: V.97, W.100, I.169
 5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:V.97, C:W.100, C:W.100, C:W.100, C:I.169
 - CLR.54: 5 residues within 4Å:- Chain D: W.263, L.302
- Ligands: POV.13, POV.14, POV.51
 2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:W.263, D:L.302
 - CLR.55: 2 residues within 4Å:- Chain D: W.23, M.30
 4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:W.23, D:W.23, D:M.30
- Hydrogen bonds: D:Q.19
 - CLR.56: 3 residues within 4Å:- Chain D: V.97, W.100, I.169
 5 PLIP interactions:5 interactions with chain D- Hydrophobic interactions: D:V.97, D:W.100, D:W.100, D:W.100, D:I.169
 
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tao, X. et al., Molecular structures of the human Slo1 K + channel in complex with beta 4. Elife (2019)
            
- Release Date
- 2019-12-25
- Peptides
- Calcium-activated potassium channel subunit alpha-1: ABCD
- SMTL:PDB
- SMTL Chain Id:
 PDB Chain Id:A
 AB
 BC
 CD
 D
- Membrane
- 
            We predict this structure to be a membrane protein. 
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 8 x CA: CALCIUM ION(Non-covalent)
- 32 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)(Non-functional Binders)
- 12 x CLR: CHOLESTEROL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tao, X. et al., Molecular structures of the human Slo1 K + channel in complex with beta 4. Elife (2019)
            
- Release Date
- 2019-12-25
- Peptides
- Calcium-activated potassium channel subunit alpha-1: ABCD
- SMTL:PDB
- SMTL Chain Id:
 PDB Chain Id:A
 AB
 BC
 CD
 D
- Membrane
- 
            We predict this structure to be a membrane protein.